Durability of class I American College of Cardiology/American Heart Association clinical practice guideline recommendations
- PMID: 24867012
- PMCID: PMC4346183
- DOI: 10.1001/jama.2014.4949
Durability of class I American College of Cardiology/American Heart Association clinical practice guideline recommendations
Abstract
Importance: Little is known regarding the durability of clinical practice guideline recommendations over time.
Objective: To characterize variations in the durability of class I ("procedure/treatment should be performed/administered") American College of Cardiology/American Heart Association (ACC/AHA) guideline recommendations.
Design, setting, and participants: Textual analysis by 4 independent reviewers of 11 guidelines published between 1998 and 2007 and revised between 2006 and 2013.
Main outcomes and measures: We abstracted all class I recommendations from the first of the 2 most recent versions of each guideline and identified corresponding recommendations in the subsequent version. We classified recommendations replaced by less determinate or contrary recommendations as having been downgraded or reversed; we classified recommendations for which no corresponding item could be identified as having been omitted. We tested for differences in the durability of recommendations according to guideline topic and underlying level of evidence using bivariable hypothesis tests and conditional logistic regression.
Results: Of 619 index recommendations, 495 (80.0%; 95% CI, 76.6%-83.1%) were retained in the subsequent guideline version, 57 (9.2%; 95% CI, 7.0%-11.8%) were downgraded or reversed, and 67 (10.8%; 95% CI, 8.4%-13.3%) were omitted. The percentage of recommendations retained varied across guidelines from 15.4% (95% CI, 1.9%-45.4%) to 94.1% (95% CI, 80.3%-99.3%; P < .001). Among recommendations with available information on level of evidence, 90.5% (95% CI, 83.2%-95.3%) of recommendations supported by multiple randomized studies were retained, vs 81.0% (95% CI, 74.8%-86.3%) of recommendations supported by 1 randomized trial or observational data and 73.7% (95% CI, 65.8%-80.5%) of recommendations supported by opinion (P = .001). After accounting for guideline-level factors, the probability of being downgraded, reversed, or omitted was greater for recommendations based on opinion (odds ratio, 3.14; 95% CI, 1.69-5.85; P < .001) or on 1 trial or observational data (odds ratio, 3.49; 95% CI, 1.45-8.41; P = .005) vs recommendations based on multiple trials.
Conclusions and relevance: The durability of class I cardiology guideline recommendations for procedures and treatments promulgated by the ACC/AHA varied across individual guidelines and levels of evidence. Downgrades, reversals, and omissions were most common among recommendations not supported by multiple randomized studies.
Conflict of interest statement
Comment in
-
Updating practice guidelines.JAMA. 2014 May;311(20):2072-3. doi: 10.1001/jama.2014.4950. JAMA. 2014. PMID: 24867011 No abstract available.
Similar articles
-
Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018.JAMA. 2019 Mar 19;321(11):1069-1080. doi: 10.1001/jama.2019.1122. JAMA. 2019. PMID: 30874755 Free PMC article.
-
Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial Fibrillation.JAMA Cardiol. 2017 Mar 1;2(3):319-323. doi: 10.1001/jamacardio.2016.4936. JAMA Cardiol. 2017. PMID: 28002833 Review.
-
Head-to-Head Comparison and Temporal Trends of Cardiac MRI Recommendations in ESC versus ACC/AHA Guidelines: A Systematic Review and Meta-Analysis.Radiol Cardiothorac Imaging. 2024 Jun;6(3):e230271. doi: 10.1148/ryct.230271. Radiol Cardiothorac Imaging. 2024. PMID: 38842455 Free PMC article.
-
Levels of evidence supporting drug, device, and other recommendations in the American Heart Association/American College of Cardiology guidelines.Am Heart J. 2020 Aug;226:4-12. doi: 10.1016/j.ahj.2020.05.003. Epub 2020 May 8. Am Heart J. 2020. PMID: 32502881
-
Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure.Ann Pharmacother. 2006 Sep;40(9):1607-17. doi: 10.1345/aph.1H059. Epub 2006 Aug 8. Ann Pharmacother. 2006. PMID: 16896019 Review.
Cited by
-
Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018.JAMA Netw Open. 2022 Mar 1;5(3):e223429. doi: 10.1001/jamanetworkopen.2022.3429. JAMA Netw Open. 2022. PMID: 35315917 Free PMC article.
-
Weekly updates of national living evidence-based guidelines: methods for the Australian living guidelines for care of people with COVID-19.J Clin Epidemiol. 2021 Mar;131:11-21. doi: 10.1016/j.jclinepi.2020.11.005. Epub 2020 Nov 11. J Clin Epidemiol. 2021. PMID: 33188858 Free PMC article.
-
Rate of change in investigational treatment options: An analysis of reports from a large precision oncology decision support effort.Int J Med Inform. 2020 Nov;143:104261. doi: 10.1016/j.ijmedinf.2020.104261. Epub 2020 Aug 24. Int J Med Inform. 2020. PMID: 32889387 Free PMC article.
-
Analysis of Temporal Trends and Variation in the Use of Defibrillation Testing in Contemporary Practice.JAMA Netw Open. 2019 Oct 2;2(10):e1913553. doi: 10.1001/jamanetworkopen.2019.13553. JAMA Netw Open. 2019. PMID: 31626314 Free PMC article.
-
Evolution of the American College of Cardiology and American Heart Association Cardiology Clinical Practice Guidelines: A 10-Year Assessment.J Am Heart Assoc. 2019 Oct;8(19):e012065. doi: 10.1161/JAHA.119.012065. Epub 2019 Sep 28. J Am Heart Assoc. 2019. PMID: 31566106 Free PMC article.
References
-
- Garber AM. Evidence-based guidelines as a foundation for performance incentives. Health Aff (Millwood) 2005;24(1):174–179. - PubMed
-
- Spertus JA, Eagle KA, Krumholz HM, Mitchell KR, Normand SL American College of Cardiology. American Heart Association Task Force on Performance Measures. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. Circulation. 2005;111(13):1703–1712. - PubMed
-
- Shekelle PG, Ortiz E, Rhodes S, et al. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated? JAMA. 2001;286(12):1461–1467. - PubMed
-
- Ortiz E, Eccles M, Grimshaw J, Woolf S. Current Validity of AHRQ Clinical Practice Guidelines. [Accessed May 7, 2014];US Agency for Healthcare Research and Quality. http://www.ncbi.nlm.nih.gov/books/NBK43864/ - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
